Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 3, 1999, Pages 711-713

  McMurry, Laura M ^a   Mcdermott, Patrick F ^a,b   Levy, Stuart B ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ISONIAZID; OXIDOREDUCTASE; TRICLOSAN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; DNA SEQUENCE; DRUG TARGETING; ESCHERICHIA COLI; GENE LOCUS; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0033055847     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.3.711     Document Type: Article

References (18)

1. Ausubel, F. M., R. Brent, R. E. Kingston, et al. (ed.). 1996. Current protocols in molecular biology, vol. 1, p. 2.4.1. John Wiley & Sons, New York, N.Y.
2. Baldock, C., J. B. Rafferty, S. E. Sedelnikova, P. J. Baker, A. R. Stuitje, A. R. Slabas, T. R. Hawkes, and D. W. Rice. 1996. A mechanism of drug action revealed by structural studies of enoyl reductase. Science 274:2107-2110.
3. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins. G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
4. Basso, L. A., B. Zheng, J. M. Musser, W. R. Jacobs, Jr., and J. S. Blanchard. 1998. Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazidresistant clinical isolates. J. Infect. Dis. 178:769-775.
5. Bhargava, H. N., and P. A. Leonard. 1996. Triclosan: applications and safety. Am. J. Infect. Control 24:209-218.
6. Cronan, J. E., Jr., and C. O. Rock. 1996. Biosynthesis of membrane lipids, p. 612-636. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C.
7. Dessen, A., A. Quemard, J. S. Blanchard, W. R. Jacobs, Jr., and J. C. Sacchettini. 1995. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267:1638-1641.
8. Donnelly-Wu, M. K., W. R. Jacobs, Jr., and G. F. Hatfull. 1993. Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria. Mol. Microbiol. 7:407-417.
9. Furia, T. E., and A. G. Schenkel. 1968. New, broad spectrum bacteriostat. Soap Chem. Spec. 44(1):47-50, 116-122.
10. Heath, R J., Y.-T. Yu, M. A. Shapiro, E. Olson, and C. O. Rock. 1998. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J. Biol. Chem. 273:30316-30320.
11. McMurry, L. M., M. Oethinger, and S. B. Levy. 1998. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 166:305-309.
12. McMurry, L. M., M. Oethinger, and S. B. Levy. 1998. Triclosan targets lipid synthesis, Nature 394:531-532.
13. Miesel, L., T. R. Weisbrod, J. A. Marcinkeviciene, R. Bittman, and W. R. Jacobs, Jr. 1998. NADH dehydrogenase defect confers isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J. Bacteriol. 180:2459-2467.
14. Neshich, G., R. Togawa, W. Viella, and B. Honig. 1998. STING (Sequence To and withIN Graphics) PDB_Viewer. Submitted to Protein Data Bank O. Newsl. 84. 15 December 1998, posting date. [Online.] http://honiglab .cpmc.columbia.edu/STING/. [28 January 1999, last date accessed.]
15. Quemard, A., J. C. Sacchettini, A. Dessen, C. Vilcheze, R. Bittman, W. R. Jacobs, Jr., and J. S. Blanchard. 1995. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34:8235-8241.
16. Rozwarski, D. A., G. A. Grant, U. H. R. Barton, W. R. Jacobs, Jr., and J. C. Sacchettini. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279:98-102.
17. Schweizer, H. P. 1998. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrob. Agents Chemother. 42:394-398.
18. Vischer, W. A., and J. Regos. 1974. Antimicrobial spectrum of triclosan, a broad-spectrum antimicrobial agent for topical application. Zentbl. Bakteriol. Hyg. Abt. 1 Orig. A 226:376-389.